<DOC>
	<DOCNO>NCT02712788</DOCNO>
	<brief_summary>The purpose study evaluate usefulness add Milrinone current standard treatment cerebral vasospasm .</brief_summary>
	<brief_title>Milrinone Addition Hyperdynamic Therapy Treatment Vasospasm Following Aneurysmal Subarachnoid Hemorrhage</brief_title>
	<detailed_description>The goal study assess efficacy milrinone agent treat cerebral vasospasm add standard therapy . This take form randomize , control trial patient receive either standard hyperdynamic therapy hyperdynamic therapy + milrinone . The hypothesis study good outcomes 25 % common experimental ( milrinone ) group control ( standard therapy ) group .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<mesh_term>Milrinone</mesh_term>
	<criteria>Subjects â‰¥ 18 year age Aneurysmal subarachnoid hemorrhage , proven CT angiogram digital subtraction angiography Aneurysm treat , either endovascular embolization surgical clip ligation Evidence increase velocity transcranial doppler ( TCDs ) and/or radiographic evidence vasospasm see angiogram Cerebral vasospasm demonstrate patient 's clinical exam ( new focal deficit change mental status attributable cause ) Recurrent subarachnoid hemorrhage Untreated ruptured aneurysm , reason Patients die prior treatment aneurysm Patients able complete least 6 month followup Patients admit already vasospasm ( i.e . delay admission ) Creatinine clearance le 20 ml/min Women positive pregnancy test lactate Other comorbidity may adversely affect patient outcome , discretion principal investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Subarachnoid Hemorrhage</keyword>
	<keyword>Cerebral Vasospasm</keyword>
	<keyword>Milrinone</keyword>
	<keyword>Hyperdynamic Therapy</keyword>
</DOC>